Valuation: Cogstate Limited

Market Cap 573M 402M 353M 333M 304M 569M 38.54B 3.99B 1.54B 19.69B 1.51B 1.48B 63.29B P/E 2027 *
26.7x
P/E 2028 * 21.4x
Enterprise Value 508M 357M 313M 296M 270M 505M 34.21B 3.54B 1.37B 17.48B 1.34B 1.31B 56.16B EV / Sales 2027 *
4.75x
EV / Sales 2028 * 4x
Free-Float
56.35%
Yield 2027 *
1.47%
Yield 2028 * 1.74%
1 day+4.01%
1 week-1.75%
Current month+9.42%
1 month+11.22%
3 months+21.22%
6 months+55.30%
Current year+49.12%
1 week 3.23
Extreme 3.23
3.5
1 month 2.95
Extreme 2.95
3.5
Current year 2.01
Extreme 2.01
3.5
1 year 1.75
Extreme 1.75
3.5
3 years 0.8
Extreme 0.795
3.5
5 years 0.8
Extreme 0.795
3.5
10 years 0.16
Extreme 0.155
3.5
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 1999-12-16
Chief Executive Officer - 2005-11-30
Director of Finance/CFO - 2021-01-31
Director TitleAgeSince
Director/Board Member - 2011-02-28
Chairman 67 2009-11-02
Director/Board Member - 2017-01-19
Date Insider Type Main position Quantity % Market Cap. Importance
5/20/26 Buy

Director

3,600 0.0021%
5/20/26 Buy

Director

430 0.0003%
4/15/26
Myer & Myer Pty Ltd.
SellCompany 9,974,569 5.8334%
Change 5-day change 1-year change 3-year change Capi.($)
+4.01%-1.75%+55.30%+117.42% 386M
-0.14%+4.33%+9.88%+31.73% 48.01B
-1.69%+1.48%+53.02%+33.59% 45.27B
+2.56%+7.34%+382.17%+594.81% 42.84B
+0.24%+2.85%+9.78%+89.54% 40.93B
-0.62%-1.11%+4.70%+46.02% 29.6B
-0.28%+1.07%+26.83%+152.91% 17.32B
-0.46%+1.20%+26.78%+41.32% 15.34B
-2.21%-4.70% - - 15.15B
+3.37%+9.21%+9.93% - 14.84B
Average +0.48%+1.28%+64.27%+138.42% 26.97B
Weighted average by Cap. +0.09%+1.77%+81.83%+153.86%

Financials

2027 *2028 *
Net sales 107M 75.14M 65.94M 62.27M 56.75M 106M 7.2B 745M 289M 3.68B 282M 276M 11.82B 123M 86.1M 75.55M 71.36M 65.03M 122M 8.25B 854M 331M 4.22B 323M 316M 13.55B
Net income 21.74M 15.27M 13.4M 12.65M 11.53M 21.58M 1.46B 151M 58.64M 747M 57.32M 56.08M 2.4B 26.89M 18.89M 16.57M 15.65M 14.26M 26.7M 1.81B 187M 72.55M 925M 70.91M 69.38M 2.97B
Net Debt -64.44M -45.26M -39.71M -37.51M -34.18M -63.99M -4.34B -449M -174M -2.22B -170M -166M -7.12B -82.01M -57.59M -50.54M -47.73M -43.5M -81.42M -5.52B -571M -221M -2.82B -216M -212M -9.06B
Logo Cogstate Limited
Cogstate Limited is a neuroscience technology company optimizing brain health assessments to advance the development of new medicines and to enable earlier clinical insights in healthcare. Its principal activities are the creation, validation, and commercialization of digital brain health assessments; and design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its segments include Clinical Trials, Healthcare, and Administration. In the Clinical Trials segment, the technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical, and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians and/or hospitals to assess cognitive decline.
Employees
160
Date Price Change Volume
26-09-25 A$3.370 +4.01% 474,110
26-09-24 A$3.240 -1.82% 268,019
26-09-23 A$3.300 -2.65% 372,215
26-09-22 A$3.390 +0.59% 87,795
26-09-21 A$3.370 -1.75% 306,466
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
3.370AUD
Average target price
3.737AUD
Spread / Average Target
+10.88%

Quarterly revenue - Rate of surprise